Mark Britton to Diabetes Mellitus, Type 2
This is a "connection" page, showing publications Mark Britton has written about Diabetes Mellitus, Type 2.
Connection Strength
0.206
-
Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus. Pharmacotherapy. 2005 Nov; 25(11):1602-20.
Score: 0.195
-
Second-generation thiazolidinediones and hepatotoxicity. Ann Pharmacother. 2004 Sep; 38(9):1419-23.
Score: 0.011